Organisation
Basic (bio-) Medical Sciences
Department
Basic and applied biomedical research, and biomedical science-based higher education.
Current researchers
1 - 10 of 155 results
- Geoffrey Aerts (Member)
- Diana Al Delbany (Member)
- Leen Ali (Member)
- Dorien Autaers (Member)
- Yoni Baert (Member)
- M.H.C. Bakkus (Member)
- Jonathan Baldan (Member)
- Jonathan Bastos (Member)
- Thomas Benoot (Member)
- Giada Bertazzon (Member)
Projects
1 - 10 of 140
- Biologic Platform for Early Detection, Prevention and Treatment of Type 1 DiabetesFrom1 Mar 2024 → TodayFunding: BOF - projects
- HERCULES: DEVELOPMENT OF NEXT-GENERATION GENE THERAPY TO TREAT GENETIC MUSCLE DISORDERSFrom1 Mar 2024 → TodayFunding: BOF - Methusalem
- POC 2023: Library sceening and hit validation for pancreatic cancerFrom1 Jan 2024 → TodayFunding: Brussels Capital Region
- Adoptive Cell Therapy Inspired On Neo-antigens (ACTION)From1 Jan 2024 → TodayFunding: Nonprofit institution or equivalents
- Prokaryote proteomics at high temperature for single cellsFrom1 Jan 2024 → TodayFunding: HORIZON.1.2 - Marie Skłodowska-Curie-actions (MSCA)
- Unravelling the anti-tumor effect of autologous myeloid dendritic cel Is plus the synthetic adjuvant AS01B in solid tumors.From1 Nov 2023 → TodayFunding: Nonprofit institution or equivalents
- Innovation Centre-3Rs Symposium 2023: ‘Emerging fields in 3Rs’From1 Aug 2023 → 31 Dec 2023Funding: FWO scientific research network
- BAXERNA 2.0 : Immunopeptidomics-based Development of Next-Generation Bacterial mRNA VaccinesFrom1 Jul 2023 → TodayFunding: HORIZON.2.1 - Health
- HERCULES: Development of an innovative muscle-directed gene therapy platform for lysosomal storage disordersFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- Liver and brain organoids to model human pluripotent stem cell tumorigenesisFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
Publications
31 - 40 of 1112
- Preimplantation Genetic Testing for Monogenic Disorders(2020)
Authors: Martine De Rijcke, Veerle Berckmoes
Pages: 1-15 - Early alteration of kidney function in non-uremic type 1 diabetic islet transplant recipients under tacrolimus-mycophenolate therapy(2014)
Authors: Pieter Gillard, Maria Rustandi, Achmad Efendi, Da Hae Lee, Zhidong Ling, Robert Hilbrands, Dirk Kuypers, Chantal Matthieu, Daniel Jacobs-Tulleneers Thevissen, F Gorus, et al.
Pages: 451-457 - Comparing a clinical protocol and fast intra-fraction update of a new motion prediction model for tumor tracking(2014)
Authors: Thomas Depuydt, Benedikt Engels, Christine Collen, Femke Steenbeke, Marlies Boussaer, M. Duchateau, Dirk Verellen
- Master's Graduate Programs in the Pharmaceutical Sciences: An International Survey(2022)
Authors: Maria Virginia Giolito
Pages: 3206-3214 - Broadening the Message(2019)
Authors: Rein Verbeke, Ine Lentacker, Karine Breckpot, Jonas Janssens, Serge Van Calenbergh, Stefaan C De Smedt, Heleen Dewitte
Pages: 1655-1669 - RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma(2023)
Authors: Martina Emde-Rajaratnam, Susanne Beck, Vladimir Benes, Hans Jürgen Salwender, Uta Bertsch, Christoph Scheid, Mathias Hänel, Katja Weisel, Thomas Hielscher, Marc S Raab, et al.
- Endothelial Zeb2 preserves the hepatic angioarchitecture and protects against liver fibrosis(2021)
Authors: Willeke de Haan, Wouter Dheedene, Katerina Apelt, Sofiane Décombas-Deschamps, Stefan Vinckier, Stefaan Verhulst, Andrea Conidi, Thomas Deffieux, Michael W Staring, Petra Vandervoort, et al.
Pages: 1262-1275 - Feasibility of markerless tumor tracking by sequential dual-energy fluoroscopy on a clinical tumor tracking system.(2015)Series: IFMBE ProceedingsVolume: 51
Authors: Jennifer Dhont, Kenneth Poels, Dirk Verellen, Koen Tournel, Femke Steenbeke
Pages: 591-594Number of pages: 4 - β₂-adrenergic agonists modulate TNF-α induced astrocytic inflammatory gene expression and brain inflammatory cell populations(2014)
Authors: Guy Laureys, Sarah Gerlo, Anneleen Spooren, Frauke Demol, Jacques De Keyser, Joeri L Aerts
- Intratumoral administration of CD1c (BDCA-1)+ and CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients(2022)
Authors: Julia Katharina Schwarze, Jens Tijtgat, Gil Awada, Louise Cras, Angela Vasaturo, Christopher Bagnall, Ramses Forsyth, Inès Dufait, Sandra Tuyaerts, Ivan Van Riet, et al.
Pages: 1-13